If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
biopharmadealmakers.nature.com | March 2019<br /> Dedicated to nurturing collaboration and partnerships in the biopharma industry<br /> What are the recent dealmaking trends in oncology?<br /> Milestone payments in biopharma deals<br /> Originally published as an advertising feature in the March 2019 editions ofFirst issue now published<br /> Nature Metabolism is an online-only journal publishing content across the full spectrum of<br /> metabolic research, from basic science studies to biomedical and translational research.<br /> Read the first issue online<br /> nature.com/natmetab<br /> @NatMetabolism<br /> A66880B3<br /> B23<br /> biopharmadealmakers.nature.com 簠Mar捨 ㈰ㄹ<br /> Dedicated to nurturing collaboration and partnerships in the biopharma industry<br /> W桡t are t桥 recent 摥a汭aki湧 tre湤猠i渠o湣o汯g礿<br /> Mi汥獴o湥 灡祭ent猠i渠扩o灨arma 摥a汳<br /> 佲iginally published as an adver<a title="BioPharma Dealmakers March 2019 page 1" href="http://viewer.zmags.com/publication/48297067?page=1"> </a> <a title="BioPharma Dealmakers March 2019 page 2" href="http://viewer.zmags.com/publication/48297067?page=2">First issue now published Nature Metabolism is </a> <a title="BioPharma Dealmakers March 2019 page 3" href="http://viewer.zmags.com/publication/48297067?page=3">B3 B23 </a> <a title="BioPharma Dealmakers March 2019 page 4" href="http://viewer.zmags.com/publication/48297067?page=4">LAUNCHING 2020 </a> <a title="BioPharma Dealmakers March 2019 page 5" href="http://viewer.zmags.com/publication/48297067?page=5">Oncology dealmaking trends Oncology remains the m</a> <a title="BioPharma Dealmakers March 2019 page 6" href="http://viewer.zmags.com/publication/48297067?page=6">feature Table 1 | Oncology licensing deals valu</a> <a title="BioPharma Dealmakers March 2019 page 7" href="http://viewer.zmags.com/publication/48297067?page=7">Table 2 | Oncology M&A deals valued at more than $</a> <a title="BioPharma Dealmakers March 2019 page 8" href="http://viewer.zmags.com/publication/48297067?page=8">feature A closer look at the technologies in</a> <a title="BioPharma Dealmakers March 2019 page 9" href="http://viewer.zmags.com/publication/48297067?page=9">ADVERTISEMENT FEATURE Faron Pharmaceuti</a> <a title="BioPharma Dealmakers March 2019 page 10" href="http://viewer.zmags.com/publication/48297067?page=10">profile Karma Oncology Ltd. is a specialized on</a> <a title="BioPharma Dealmakers March 2019 page 11" href="http://viewer.zmags.com/publication/48297067?page=11">ADVERTISEMENT FEATURE Polaris Pharmaceu</a> <a title="BioPharma Dealmakers March 2019 page 12" href="http://viewer.zmags.com/publication/48297067?page=12">profile Since 2016, Elucida Oncology has been foc</a> <a title="BioPharma Dealmakers March 2019 page 13" href="http://viewer.zmags.com/publication/48297067?page=13">ADVERTISEMENT FEATURE YUMAB GmbH www.y</a> <a title="BioPharma Dealmakers March 2019 page 14" href="http://viewer.zmags.com/publication/48297067?page=14">profile Immuno-oncology, a concept that uses th</a> <a title="BioPharma Dealmakers March 2019 page 15" href="http://viewer.zmags.com/publication/48297067?page=15">ADVERTISEMENT FEATURE Delta-Fly Pharma </a> <a title="BioPharma Dealmakers March 2019 page 16" href="http://viewer.zmags.com/publication/48297067?page=16">profile A decisive factor in whether mutating c</a> <a title="BioPharma Dealmakers March 2019 page 17" href="http://viewer.zmags.com/publication/48297067?page=17">ADVERTISEMENT FEATURE Oncopeptides AB </a> <a title="BioPharma Dealmakers March 2019 page 18" href="http://viewer.zmags.com/publication/48297067?page=18">profile ADVERTISEMENT FEATURE Immune</a> <a title="BioPharma Dealmakers March 2019 page 19" href="http://viewer.zmags.com/publication/48297067?page=19">ADVERTISEMENT FEATURE TOLREMO therapeut</a> <a title="BioPharma Dealmakers March 2019 page 20" href="http://viewer.zmags.com/publication/48297067?page=20">profile In recent years, checkpoint inhibitors </a> <a title="BioPharma Dealmakers March 2019 page 21" href="http://viewer.zmags.com/publication/48297067?page=21">ADVERTISEMENT FEATURE Cristal Therapeut</a> <a title="BioPharma Dealmakers March 2019 page 22" href="http://viewer.zmags.com/publication/48297067?page=22">profile ADVERTISEMENT FEATURE Ligand</a> <a title="BioPharma Dealmakers March 2019 page 23" href="http://viewer.zmags.com/publication/48297067?page=23">ADVERTISEMENT FEATURE Versatile platform ma</a> <a title="BioPharma Dealmakers March 2019 page 24" href="http://viewer.zmags.com/publication/48297067?page=24">profile ADVERTISEMENT FEATURE Actym </a> <a title="BioPharma Dealmakers March 2019 page 25" href="http://viewer.zmags.com/publication/48297067?page=25">Milestone payments in biopharma: negotiating an </a> <a title="BioPharma Dealmakers March 2019 page 26" href="http://viewer.zmags.com/publication/48297067?page=26">feature Fig. 1 | Development stage of biopharma a</a> <a title="BioPharma Dealmakers March 2019 page 27" href="http://viewer.zmags.com/publication/48297067?page=27">ADVERTISEMENT FEATURE Sobi www.sobi.co</a> <a title="BioPharma Dealmakers March 2019 page 28" href="http://viewer.zmags.com/publication/48297067?page=28">profile The Korea Drug Development Fund (KDDF) is</a> <a title="BioPharma Dealmakers March 2019 page 29" href="http://viewer.zmags.com/publication/48297067?page=29">ADVERTISEMENT FEATURE Ipsen www.ipsen.</a> <a title="BioPharma Dealmakers March 2019 page 30" href="http://viewer.zmags.com/publication/48297067?page=30">profile ADVERTISEMENT FEATURE Admedu</a> <a title="BioPharma Dealmakers March 2019 page 31" href="http://viewer.zmags.com/publication/48297067?page=31">OPEN ACCESS MULTIDIS</a> <a title="BioPharma Dealmakers March 2019 page 32" href="http://viewer.zmags.com/publication/48297067?page=32">Translational and clinical medicine from Nature </a>